Stoke Therapeutics (STOK) Other Non Operating Income (2019 - 2026)
Stoke Therapeutics' quarterly Other Non Operating Income came in at $18000.0 in Q1 2026, down 35.71% year-on-year from $28000.0 in Q1 2025, and up 116.36% quarter-over-quarter from -$110000.0 in Q4 2025.
Stoke Therapeutics has reported Other Non Operating Income for 8 years, with the latest figure at $18000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income fell 35.71% year-over-year to $18000.0; the trailing twelve-month figure through Mar 2026 stood at -$61000.0 (down 129.19% YoY), and the FY2025 full-year result was -$51000.0, up 79.35% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $18000.0, up from -$110000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $201000.0 in Q4 2024, with the low at -$428000.0 in Q1 2024.
- Average Other Non Operating Income over 5 years is $3117.6, with a median of $41000.0 recorded in 2023.
- Peak annual rise in Other Non Operating Income reached 390.24% in 2024, while the deepest fall reached 1119.05% in 2024.
- Tracing STOK's Other Non Operating Income over 5 years: stood at $42000.0 in 2022, then retreated by 2.38% to $41000.0 in 2023, then surged by 390.24% to $201000.0 in 2024, then sank by 154.73% to -$110000.0 in 2025, then soared by 116.36% to $18000.0 in 2026.
- The last three Other Non Operating Income figures came in at $18000.0 (Q1 2026), -$110000.0 (Q4 2025), and $3000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Stoke Therapeutics | 1.92 Bn | 1.92 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18,000.00 |
| Dec 31, 2025 | -110,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 28,000.00 |
| Mar 31, 2025 | 28,000.00 |
| Dec 31, 2024 | 201,000.00 |
| Sep 30, 2024 | 28,000.00 |
| Jun 30, 2024 | -48,000.00 |
| Mar 31, 2024 | -428,000.00 |
| Dec 31, 2023 | 41,000.00 |
| Sep 30, 2023 | 41,000.00 |
| Jun 30, 2023 | 41,000.00 |
| Mar 31, 2023 | 42,000.00 |
| Dec 31, 2022 | 42,000.00 |
| Sep 30, 2022 | 42,000.00 |
| Jun 30, 2022 | 42,000.00 |
| Mar 31, 2022 | 42,000.00 |
| Dec 31, 2021 | 42,000.00 |
| Sep 30, 2021 | 42,000.00 |
| Jun 30, 2021 | 28,000.00 |
| Mar 31, 2021 | 28,000.00 |
| Dec 31, 2020 | 28,000.00 |
| Sep 30, 2020 | 28,000.00 |
| Jun 30, 2020 | 14,000.00 |
| Mar 31, 2020 | 22,000.00 |
| Dec 31, 2019 | 4,000.00 |
| Sep 30, 2019 | 2,000.00 |
| Jun 30, 2019 | -3,000.00 |